Grace Alba

Grace Alba is a scientist at Genentech, specializing in formulation development for solid and liquid dosages. With 17 years of experience in drug product development, they have focused on parenteral drug products, solid oral dosage forms, and small molecule preformulation support. Their previous roles include positions at Amgen and Theravance, where they contributed to formulation screening, stability assessment, and support for IND and NDA filings. Grace holds a degree in Biochemistry from the University of California, Davis.